Skip to main content
Premium Trial:

Request an Annual Quote

Genome Therapeutics, Amgen Ink Drug-Discovery Pact

NEW YORK, Jan. 2 - Genome Therapeutics today said it will help Amgen discover and develop therapeutics for certain bone diseases.


While Genome Therapeutics would not detail the way it will work with the drug giant, the company stressed it will be a company-wide effort that will include its GenomeVision services and the human genetics department.


Genome Therapeutics will receive an undisclosed upfront payment, sponsored research funding, and stands to pocket milestones and "other downstream consideration" tied to the success of the collaboration.


Click here for more information.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.